Bhattacharya is a physician and professor at Stanford University School of Medicine, and is a critic of pandemic lockdowns ...

Photo: Paramedics attend to a man who is overdosing, in the Drexel neighborhood of Dayton, Ohio, on Aug. 3, 2017. The Epoch ...

A recent study by North Carolina State University exposes a critical shortfall in opioid treatment availability within the ...

Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...

Seven months ago, Cindy Jacquet came home after running errands with her daughter to find her son's car parked in front of ...

The FDA approved the first over-the-counter drug, naloxone nasal spray, last year to help reduce drug overdose deaths.

Opioid agonists are the gold standard for the treatment of OUD but have not been able to solve the opioid crisis.

The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for the emergency treatment of known or suspected opioid overdose in adults an ...

Vertex expects to hear from the FDA by the end of January if suzetrigine will be approved ... albeit not more so than a ...

New litigation centered on increasing access to substance-use disorder treatment in jails and prisons is helping to reduce ...

A BuzzFeed News analysis shows the role of fentanyl in this staggering trend. The Golden State Killer’s genome was shared with cold-case experts years ago, and genealogy sleuths have been working ever ...

You may have heard of the painkiller OxyContin and wonder about its pros and cons. To help you better weigh its benefits and ...